Literature DB >> 17982892

Serum lipoprotein profile and APOE genotype in Alzheimer's disease.

A Cagnin1, A Zambon, G Zarantonello, D Vianello, M Marchiori, D Mercurio, F Miccichè, M Ermani, A Leon, L Battistin.   

Abstract

Alterations in cholesterol homeostasis are associated with Alzheimer's disease (AD). The role played by specific fractions of serum lipoproteins in modifying the risk of AD, and the interaction with APOE genotype has not yet been investigated. We studied serum lipoprotein profiles using a gradient-density ultracentrifugation method in a cohort of late-onset sporadic AD patients without cerebrovascular lesions and in healthy elderly subjects. In the AD group the lipoprotein cholesterol distribution showed an increase in LDL cholesterol, reaching a significant difference with respect to controls in the LDL sub-fractions representing the transition between small dense-LDL (fraction 11, p = 0.04) and normal-density LDL particles (fraction 12, p = 0.03). APOE genotype and LDL cholesterol were independently associated with AD. The mean concentration of LDL in fractions 11 and 12 increased the risk of developing AD (p = 0.01 and p = 0.025, respectively). These results confirm that an alteration of cholesterol homeostasis is associated with AD and that serum concentrations of LDL cholesterol are higher in AD patients without cerebrovascular pathology than in elderly normal subjects. The presence of the APOE epsilon4+ allele is a risk factor for AD independent of increased serum cholesterol or a modification of other vascular risk factors. Increased levels of specific sub-fractions of LDL cholesterol may be associated with increased risk of AD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17982892     DOI: 10.1007/978-3-211-73574-9_22

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  6 in total

1.  The Alzheimer's Prevention Clinic at Weill Cornell Medical College / New York - Presbyterian Hospital: Risk Stratification and Personalized Early Intervention.

Authors:  A Seifan; R Isaacson
Journal:  J Prev Alzheimers Dis       Date:  2015-10-01

Review 2.  Vascular cognitive disorder. A biological and clinical overview.

Authors:  Leontino Battistin; Annachiara Cagnin
Journal:  Neurochem Res       Date:  2010-12-03       Impact factor: 3.996

3.  Mild cognitive impairment associates with concurrent decreases in serum cholesterol and cholesterol-related lipoprotein subclasses.

Authors:  T Tukiainen; P Jylänki; V P Mäkinen; O Gröhn; M Hallikainen; H Soininen; M Kivipelto; K Kaski; P H Groop; M J Savolainen; T Pirttilä; P Soininen; M Ala-Korpela
Journal:  J Nutr Health Aging       Date:  2012-07       Impact factor: 4.075

4.  The relation between serum lipids and lutein and zeaxanthin in the serum and retina: results from cross-sectional, case-control and case study designs.

Authors:  Lisa M Renzi; Billy R Hammond; Melissa Dengler; Richard Roberts
Journal:  Lipids Health Dis       Date:  2012-02-29       Impact factor: 3.876

Review 5.  Biomarkers for early diagnosis of Alzheimer disease: 'ALZheimer ASsociated gene'--a new blood biomarker?

Authors:  Kurt A Jellinger; Bernd Janetzky; Johannes Attems; Elisabeth Kienzl
Journal:  J Cell Mol Med       Date:  2008-03-19       Impact factor: 5.310

6.  Study on the Association of Dietary Fatty Acid Intake and Serum Lipid Profiles With Cognition in Aged Subjects With Type 2 Diabetes Mellitus.

Authors:  Pengfei Li; Yanyan Gao; Xiaojun Ma; Shaobo Zhou; Yujie Guo; Jingjing Xu; Xixiang Wang; Nicholas Van Halm-Lutterodt; Linhong Yuan
Journal:  Front Aging Neurosci       Date:  2022-03-31       Impact factor: 5.750

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.